London Daily

Focus on the big picture.
Thursday, Oct 30, 2025

UK approves first COVID antiviral pill for use

UK approves first COVID antiviral pill for use

The United Kingdom (UK) has become the first country globally to approve a COVID-19 antiviral pill jointly developed by US-based Merck & Co Inc and Ridgeback Biotherapeutics.

The potentially game-changing drug, molnupriavir, was recommended by Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) for use in people who suffer from mild to moderate symptoms of COVID-19 and have at least one risk factor for developing severe illness which includes obesity, Type 2 diabetes and heart disease.

The drug will be administered to patients who test positive for the coronavirus and within five days of the onset of symptoms.

The MHRA said this determination is made by clinical data gathered throughout the trial phases of the drug.

The approval for the pill is the first for an oral antiviral COVID-19 treatment worldwide and it will be the very first time the drug will be administered on a wide-scale community level.

FDA to review drug’s safety this month


Food and Drug Administration (FDA) advisers from the United States are expected to meet on November 30 of this month to review the drug’s safety and efficacy and vote on whether the drug should be authorised for use in the US.

The pill, which is expected to be branded as Lageviro in the UK, has been designed to reprogram the genetic coding of the COVID-19 and introduce errors. The pill will be taken twice a day for at least five days.

The pill will be a welcomed addition for many people across the world as treatments to tackle the impacts of the virus are mainly focused on vaccines.

Also, the data by Merck’s on the pill has shown it could slash the possibility of dying or being severely hospitalised by COVID-19 by 50 percent.

Wider roll-out


A wider rollout will follow if it is clinically and cost-effective in reducing hospitalisations and death.

If the pill proves to be successful in the UK, it could mean good news for the Virgin Islands and other Caribbean states as they try to deal with the impacts of the pandemic. While the Virgin Islands has had higher uptake of the vaccines among citizens in comparison to other countries in the Caribbean, there is still some level of vaccine hesitancy in the territory.

However, this antiviral treatment provides an alternative for the vaccine. The statistics show that a little more than 52 percent of the population is fully vaccinated while six per cent has received its first dose of a two-dose vaccine.

While many people may have questions surrounding the validity of the antiviral drug because other drugs in the same class as molnupiravir has been linked to birth defects in animals, Merck & Co Inc said its testing data on animals indicate it is completely safe for use. However, the data is not yet made available to the public.

Newsletter

Related Articles

0:00
0:00
Close
UK and Vietnam Sign Landmark Migration Deal to Fast-Track Returns of Irregular Arrivals
UK Drug-Pricing Overhaul Essential for Life-Sciences Ambition, Says GSK Chief
Princesses Beatrice and Eugenie Temporarily Leave the UK Amid Their Parents’ Royal Fallout
UK Weighs Early End to Oil and Gas Windfall Tax as Reeves Seeks Investment Commitments
UK Retail Inflation Slows as Shop Prices Fall for First Time Since Spring
Next Raises Full-Year Profit Guidance After Strong Third-Quarter Performance
Reform UK’s Lee Anderson Admits to 'Gaming' Benefits System While Advocating Crackdown
United States and South Korea Conclude Major Trade Accord Worth $350 Billion
Hurricane Melissa Strikes Cuba After Devastating Jamaica With Record Winds
Vice President Vance to Headline Turning Point USA Campus Event at Ole Miss
U.S. Targets Maritime Narco-Routes While Border Pressure to Mexico Remains Limited
Bill Gates at 70: “I Have a Real Fear of Artificial Intelligence – and Also Regret”
Elon Musk Unveils Grokipedia: An AI-Driven Alternative to Wikipedia
Saudi Arabia Unveils Vision for First-Ever "Sky Stadium" Suspended Over Desert Floor
Amazon Announces 14 000 Corporate Job Cuts as AI Investment Accelerates
UK Shop Prices Fall for First Time Since March, Food Leads the Decline
London Stock Exchange Group ADR (LNSTY) Earns Zacks Rank #1 Upgrade on Rising Earnings Outlook
Soap legend Tony Adams, long-time star of Crossroads, dies at 84
Rachel Reeves Signals Tax Increases Ahead of November Budget Amid £20-50 Billion Fiscal Gap
NatWest Past Gains of 314% Spotlight Opportunity — But Some Key Risks Remain
UK Launches ‘Golden Age’ of Nuclear with £38 Billion Sizewell C Approval
UK Announces £1.08 Billion Budget for Offshore Wind Auction to Boost 2030 Capacity
UK Seeks Steel Alliance with EU and US to Counter China’s Over-Capacity
UK Struggles to Balance China as Both Strategic Threat and Valued Trading Partner
Argentina’s Markets Surge as Milei’s Party Secures Major Win
British Journalist Sami Hamdi Detained by U.S. Authorities After Visa Revocation Amid Israel-Gaza Commentary
King Charles Unveils UK’s First LGBT+ Armed Forces Memorial at National Memorial Arboretum
At ninety-two and re-elected: Paul Biya secures eighth term in Cameroon amid unrest
Racist Incidents Against UK Nurses Surge by 55%
UK Chancellor Rachel Reeves Cites Shared Concerns With Trump Administration as Foundation for Early US-UK Trade Deal
Essentra plc: A Closer Look at a UK ‘Penny Stock’ Opportunity Amid Market Weakness
U.S. and China Near Deal to Avert Rare-Earth Export Controls Ahead of Trump-Xi Summit
Justin time: Justin Herbert Shields Madison Beer with Impressive Reflex at Lakers Game
Russia’s President Putin Declares Burevestnik Nuclear Cruise Missile Ready for Deployment
Giuffre’s Memoir Alleges Maxwell Claimed Sexual Act with Clooney
House Republicans Move to Strip NYC Mayoral Front-Runner Zohran Mamdani of U.S. Citizenship
Record-High Spoiled Ballots Signal Voter Discontent in Ireland’s 2025 Presidential Election
Philippines’ Taal Volcano Erupts Overnight with 2.4 km Ash Plume
Albania’s Virtual AI 'Minister' Diella Set to 'Birth' Eighty-Three Digital Assistants for MPs
Tesla Unveils Vision for Optimus V3 as ‘Biggest Product of All Time’, Including Surgical Capabilities
Francis Ford Coppola Auctions Luxury Watches After Self-Financed Film Flop
Convicted Sex Offender Mistakenly Freed by UK Prison Service Arrested in London
United States and China Begin Constructive Trade Negotiations Ahead of Trump–Xi Summit
U.S. Treasury Sanctions Colombia’s President Gustavo Petro over Drug-Trafficking Allegations
Miss USA Crowns Nebraska’s Audrey Eckert Amid Leadership Overhaul
‘I Am Not Done’: Kamala Harris Signals Possible 2028 White House Run
NBA Faces Integrity Crisis After Mass Arrests in Gambling Scandal
Swift Heist at the Louvre Sees Eight French Crown Jewels Stolen in Under Seven Minutes
U.S. Halts Trade Talks with Canada After Ontario Ad Using Reagan Voice Triggers Diplomatic Fallout
Microsoft AI CEO: ‘We’re making an AI that you can trust your kids to use’ — but can Microsoft rebuild its own trust before fixing the industry’s?
×